Abstract | INTRODUCTION:
Neurogenic bowel dysfunction resulting from spinal cord injury (SCI) frequently requires bowel care (BC) with stimulant suppositories for initiation of effective defecation. The excessive time required for BC and bowel complications have limited quality of life after SCI. OBJECTIVE: SETTING: Inpatient SCI medicine unit. SUBJECTS: Fourteen persons with SCI with chronic stable paralysis from upper motor neuron SCI for greater than one year with a stable HVB bisacodyl suppository initiated BC. DESIGN: Crossover Controlled. METHOD: OUTCOME MEASURES: BC event times were utilized to derive BC intervals: suppository insertion to first flatus= Time to flatus, first flatus until the beginning of stool flow = Flatus to stool flow, begin stool flow until end stool flow = Defecation period, end stool flow until end of clean up = Clean up, and suppository insertion until end clean up = Total bowel care time. RESULTS: The data included two groups of BC sessions: HVB (n = 84) and PGB (n = 81). Mean times in minutes and P values from t tests for paired samples yielded: Time to flatus: (HVB 31, PGB 12.8 P < 0.002), Defecation period: (HVB 58, PGB 32, P < 0.0005), Clean up: (HVB 1.9, PGB 3.2 P = 0.165), Total bowel care time: (HVB 102, PGB 51.2 P < 0.0005). CONCLUSION:
|
Authors | S A Stiens, W Luttrel, J E Binard |
Journal | Spinal cord
(Spinal Cord)
Vol. 36
Issue 11
Pg. 777-81
(Nov 1998)
ISSN: 1362-4393 [Print] England |
PMID | 9848486
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cathartics
- Plant Oils
- Suppositories
- Surface-Active Agents
- Bisacodyl
- Polyethylene Glycols
|
Topics |
- Bisacodyl
(administration & dosage, therapeutic use)
- Cathartics
(administration & dosage, therapeutic use)
- Constipation
(drug therapy, etiology)
- Cross-Over Studies
- Defecation
(drug effects)
- Humans
- Male
- Middle Aged
- Plant Oils
(administration & dosage, therapeutic use)
- Polyethylene Glycols
(administration & dosage, therapeutic use)
- Spinal Cord Injuries
(complications)
- Suppositories
- Surface-Active Agents
(administration & dosage, therapeutic use)
- Time Factors
- Treatment Outcome
|